Phil’s Journal: Dog Dementia, or Bea’s Story
By
Phil Gutis
| September 29th, 2022
Sometimes I look up and see my future staring at me, wagging her tail. Her name is Beatrice. She’s a 16-year-old cattle dog mix…
The Next Disease-Modifying Alzheimer’s Drug? Lecanemab Trial Results Looking Good
By
Simon Spichak, MSc
| September 28th, 2022
Drugmakers Eisai and Biogen just announced the success of their latest Phase 3 trial for the Alzheimer’s anti-amyloid drug lecanemab, setting the stage for…
An Electric Jolt to the Brain May Boost Memory—But Don’t Get Too Fired Up
By
Simon Spichak, MSc
| September 27th, 2022
Every second, the 100 billion neurons in your brain fire off five to 50 electrical messages. This encodes instructions that are important for everything…
Donald Weaver: Alzheimer’s As an Autoimmune Disease
By
Donald Weaver
| September 26th, 2022
The pursuit of a cure for Alzheimer’s disease is becoming an increasingly competitive and contentious quest with recent years witnessing several important controversies. In…
Nightmare After Nightmare: Study Links Bad Dreams and Dementia
By
Abidemi Otaiku, University of Birmingham
| September 23rd, 2022
University of Birmingham neurology fellow and dreams researcher Abidemi Otaiku discusses his new study on nightmares as a possible predictor of cognitive decline or…
Genetic Origami: How Misfolded DNA Could Lead to Alzheimer’s
By
Simon Spichak, MSc
| September 22nd, 2022
Like an aged book, DNA in the brain acquires wear and tear during your lifespan. Earlier this year, researchers from Brigham and Women’s Hospital…
Phil’s Journal: Why Voices of Alzheimer’s? Because ‘Silence Equals Death’
By
Phil Gutis
| September 21st, 2022
During the height of the AIDS crisis 35 years ago, a few hundred people gathered one night in the NYC Lesbian and Gay Community…
Far Out: New Psychedelic for Alzheimer’s Depression Heads to Trials
By
Simon Spichak, MSc
| September 20th, 2022
Biomind Labs is testing whether the highs of a synthetic psychedelic can help people with Alzheimer’s treat symptoms of depression. Psychedelics have been a…
The Brain That Defied Alzheimer’s
By
Simon Spichak, MSc
| September 19th, 2022
Scientists examine the curious case of a woman with genes for early-onset Alzheimer’s who never developed the disease. In an autopsied brain, they found…
The 1% Throw Down Millions to Fix Alzheimer’s Diagnostics
By
Simon Spichak, MSc
| September 16th, 2022
Even though Alzheimer’s may start 20 years before symptoms first appear, there are no non-invasive diagnostics to detect it. An initiative called the Diagnostics…
Leading With Love: Ty Lewis Amplifies the Voice of Black Caregivers
By
Lonna Whiting
| September 15th, 2022
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Like most dementia caregivers, Ty…
Can Multivitamins Prevent Cognitive Aging? Here’s the Real Story
By
Simon Spichak, MSc
| September 14th, 2022
For thousands of years, people have told myths about fountains, concoctions, and elixirs with incredible rejuvenating powers. The myth has persisted into modernity, the…
Don’t Just Whistle While You Work — Engage the Brain While You Sit
By
Becca Schuh
| September 14th, 2022
While too much sedentary time sitting around can be bad for brain health, but a new study adds that what you do while you…
Dementia Companion: Robo Caregivers Are Coming to Help
By
Simon Spichak, MSc
| September 13th, 2022
It is the year 2022, and a robot from the not-so-distant future has traveled back in time. Unlike Arnold Schwarzenegger’s Terminator, the robot does…
How Much Does Aduhelm Cost?
By
Simon Spichak, MSc
| September 12th, 2022
UPDATE: 3 March 2024, 8:13 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…